Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Adverum Biotechnologies Inc

ADVM
Current price
0.88 USD +0.069 USD (+8.51%)
Last closed 0.83 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 83 599 840 USD
Yield for 12 month +33.52 %
Week
Month
Year
ADVM
21.11.2021 - 28.11.2021

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ixoberogene soroparvovec (ADVM-022), a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. The company is developing ADVM-062 (AAV.7m8-L-opsin), a novel gene therapy product candidate for the treatment of blue cone monochromacy via a single IVT injection. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; GenSight Biologics; Lexeo Therapeutics; and Virovek, Inc. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California. Address: 800 Saginaw Drive, Redwood City, CA, United States, 94063

Analytics

WallStreet Target Price

3.8 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+7 500 000 USD

Current Quarter

Last Quarter

Current Year

Last Year

+7 500 000 USD

Current Quarter

Last Quarter

Key Figures ADVM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -120 613 000 USD
Operating Margin TTM -3526.67 %
PE Ratio
Return On Assets TTM -29.99 %
PEG Ratio
Return On Equity TTM -81.14 %
Wall Street Target Price 3.8 USD
Revenue TTM 3 600 000 USD
Book Value 1.02 USD
Revenue Per Share TTM 0.036 USD
Dividend Share
Quarterly Revenue Growth YOY -70 %
Dividend Yield
Gross Profit TTM -81 681 000 USD
Earnings Share -1.26 USD
Diluted Eps TTM -1.26 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ADVM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ADVM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ADVM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 11.6755
Price Sales TTM 23.2222
Enterprise Value EBITDA -0.3351
Price Book MRQ 0.8138

Financials ADVM

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ADVM

For 52 weeks

0.53 USD 2.34 USD
50 Day MA 1.03 USD
Shares Short Prior Month 1 350 474
200 Day MA 1.22 USD
Short Ratio 5.26
Shares Short 1 487 123
Short Percent 1.49 %